Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Brl 38705
2. Brl-38705
3. Epsiprantel, (+)-isomer
4. Epsiprantel, (-)-isomer
1. Cestex
2. 98123-83-2
3. Epsiprantel, (+)-
4. Epsiprantel, (-)-
5. Brl 38705
6. 0c1spq0fsr
7. Wuc74dw9sn
8. Ju2x6k5bl3
9. Brl38705
10. Epsiprantel (inn)
11. Brl-38705
12. Epsiprantel [inn]
13. (+-)-2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydropyrazino(2,1-a)(2)benzazepin-4(1h)-one
14. Pyrazino[2,1-a][2]benzazepin-4(1h)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro-
15. Brl38705;brl-38705;brl 38705
16. Epsiprantelum
17. (+)-2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydropyrazino(2,1-a)(2)benzazepin-4(1h)-one
18. (-)-2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydropyrazino(2,1-a)(2)benzazepin-4(1h)-one
19. 98123-66-1
20. 98123-67-2
21. Pyrazino(2,1-a)(2)benzazepin-4(1h)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro-, (+)-
22. Pyrazino(2,1-a)(2)benzazepin-4(1h)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro-, (-)-
23. Epsiprantelum [latin]
24. Epsiprantel [inn:ban]
25. Unii-0c1spq0fsr
26. Pyrazino(2,1-a)(2)benzazepin-4(1h)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro-
27. Cestex (tn)
28. Epsiprantel [mi]
29. Unii-wuc74dw9sn
30. Unii-ju2x6k5bl3
31. 2-(cyclohexanecarbonyl)-1,3,6,7,8,12b-hexahydropyrazino[2,1-a][2]benzazepin-4-one
32. Dsstox_cid_31392
33. Dsstox_rid_97531
34. Epsiprantel [mart.]
35. Dsstox_gsid_57858
36. Chembl64979
37. Schembl165343
38. Dtxsid3057858
39. Epsiprantel [green Book]
40. Tox21_113678
41. Ncgc00249902-01
42. Cas-98123-83-2
43. D07903
44. Q1347716
45. 2-(cyclohexylcarbonyl)-4-oxo-1,2,3,4,6,7,8,12b-octahydropyrazino[2,1-a][2]benzazepine
46. (+/-)-2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydropyrazino(2,1-a)(2)benzazepin-4(1h)-one
47. 2-cyclohexylcarbonyl-2,3,6,7,8,12b-hexahydropyrazino(2,1-a)(2)benzazepin-4(1h)-one
Molecular Weight | 326.4 g/mol |
---|---|
Molecular Formula | C20H26N2O2 |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 326.199428076 g/mol |
Monoisotopic Mass | 326.199428076 g/mol |
Topological Polar Surface Area | 40.6 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 486 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
64
PharmaCompass offers a list of Epsiprantel API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Epsiprantel manufacturer or Epsiprantel supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Epsiprantel manufacturer or Epsiprantel supplier.
PharmaCompass also assists you with knowing the Epsiprantel API Price utilized in the formulation of products. Epsiprantel API Price is not always fixed or binding as the Epsiprantel Price is obtained through a variety of data sources. The Epsiprantel Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_31392 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_31392, including repackagers and relabelers. The FDA regulates DSSTox_CID_31392 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_31392 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_31392 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_31392 supplier is an individual or a company that provides DSSTox_CID_31392 active pharmaceutical ingredient (API) or DSSTox_CID_31392 finished formulations upon request. The DSSTox_CID_31392 suppliers may include DSSTox_CID_31392 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_31392 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DSSTox_CID_31392 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DSSTox_CID_31392 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DSSTox_CID_31392 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DSSTox_CID_31392 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DSSTox_CID_31392 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DSSTox_CID_31392 suppliers with NDC on PharmaCompass.
DSSTox_CID_31392 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_31392 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_31392 GMP manufacturer or DSSTox_CID_31392 GMP API supplier for your needs.
A DSSTox_CID_31392 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_31392's compliance with DSSTox_CID_31392 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_31392 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_31392 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_31392 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_31392 EP), DSSTox_CID_31392 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_31392 USP).